Integra Lifesciences Holdings (IART) Is Falling After Q3 Report

Shutterstock photo

(RTTNews.com) - Integra Lifesciences Holdings ( IART ) reported third quarter adjusted EPS of $0.59 Wednesday morning, which was in line with analysts' expectations.

The company continues to expect to report full year adjusted EPS of $2.36 to $2.42. However, the company lowered its full-year revenue guidance to a range of $1.467 billion to $1.472 billion, from the prior forecast range of between $1.475 billion and $1.490 billion.

Integra Lifesciences Holdings gapped open sharply lower this morning and is now down 8.64 at $53.68. The stock has dropped to nearly a 7-month low.

Read the original article on RTTNews (http://www.rttnews.com/2949786/integra-lifesciences-holdings-iart-is-falling-after-q3-report.aspx)

For comments and feedback: contact editorial@rttnews.com

This article appears in: Stocks
Referenced Symbols: IART

More from RTT News


See All RTT news

Research Brokers before you trade

Want to trade FX?